4,5-dimethyl-1,3-dihydro-2H-indol-2-one | 100487-72-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 4,5-dimethyl-1,3-dihydro-2H-indol-2-one
• 英文别名: 4,5-dimethyl-1,3-dihydroindol-2-one
• CAS: 100487-72-7
• 化学式: C₁₀H₁₁NO
• 分子量: 161.2
• InChiKey: DCWSRBDYLSWXIS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (S)-N-<<3-(4-formylphenyl)-2-oxo-5-oxazolidinyl>methyl>acetamide 、 、 4,5-dimethyl-1,3-dihydro-2H-indol-2-one 、 哌啶 在 silica gel 、 methanol-dichloromethane 作用下， 以 乙醇 为溶剂， 反应 48.0h， 生成 N-(((5S)-3-(4-((Z)-(4,5-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)phenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide
  参考文献：
  名称：

  Oxazolidinone antibacterial agents

  摘要：

  化学式为(I)1的化合物或其治疗上可接受的盐，可用于治疗细菌感染。本文揭示了该化合物的制备、含有该化合物的组合物以及使用该化合物治疗疾病的方法。

  公开号：

  US20020091107A1
• 作为产物：
  描述：

  4,5-二甲基靛红 生成 4,5-dimethyl-1,3-dihydro-2H-indol-2-one
  参考文献：
  名称：

  KADIN, SAUL B.

  摘要：

  DOI：

文献信息

• NOVEL BENZIMIDAZOLE DERIVATIVE AND USE THEREOF
  申请人：HYOGO COLLEGE OF MEDICINE

  公开号：US20150011600A1

  公开（公告）日：2015-01-08

  The present invention aims to provide a compound capable of inhibiting PCA-1 that can be a target for a novel treatment method of various diseases, and pharmaceutical use of the compound. A compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof.

  本发明旨在提供一种能够抑制PCA-1的化合物，该化合物可作为各种疾病的新型治疗方法的靶点，并且可用于制药的该化合物。一种由以下化学式（I）表示的化合物：其中每个符号如描述中定义的，或其药用盐。
• Indolinone combinatorial libraries and related products and methods for the treatment of disease
  申请人：Tang Cho Peng

  公开号：US20050197382A1

  公开（公告）日：2005-09-08

  The present invention relates to organic molecules capable of modulating, regulating and/or inhibiting protein kinase signal transduction. Such compounds are useful for the treatment of diseases related to unregulated protein kinase signal transduction, including cell proliferative diseases such as cancer, atherosclerosis, arthritis and restenosis and metabolic diseases such as diabetes. The present invention features indolinone compounds that potently inhibit protein kinases and related products and methods. Inhibitors specific to the FLK protein kinase can be obtained by adding chemical substituents to the 3-[(indole-3-yl)methylene]-2-indolinone, in particular at the 1′ position of the indole ring. Indolinone compounds that specifically inhibit the FLK and platelet derived growth factor protein kinases can harbor a tetrahydroindole or cyclopentano-b-pyrrol moiety. Indolinone compounds that are modified with substituents, particularly at the 5 position of the oxindole ring, can effectively activate protein kinases. This invention also features novel hydrosoluble indolinone compounds that are tyrosine kinase inhibitors and related products and methods.

  本发明涉及有机分子，能够调节、调控和/或抑制蛋白激酶信号转导。这些化合物对于治疗与不受调节的蛋白激酶信号转导相关的疾病非常有用，包括细胞增殖性疾病，如癌症、动脉粥样硬化、关节炎、再狭窄和代谢性疾病，如糖尿病。本发明涉及具有强效抑制蛋白激酶和相关产品以及方法的吲哚酮化合物。特定于FLK蛋白激酶的抑制剂可以通过在吲哚环的1'位置添加化学取代基来获得3-[(吲哚-3-基)亚甲基]-2-吲哚酮。特异性抑制FLK和血小板衍生生长因子蛋白激酶的吲哚酮化合物可以具有四氢吲哚或环戊烯基-β-吡咯基。在氧吲哚环的5位取代基的修饰下，吲哚酮化合物可以有效激活蛋白激酶。本发明还涉及新型水溶性吲哚酮化合物，它们是酪氨酸激酶抑制剂和相关产品和方法。
• Unsaturated Heterocyclic Derivatives
  申请人：Wang Yihan

  公开号：US20120178716A1

  公开（公告）日：2012-07-12

  This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.

  本发明涉及一般式化合物：其中变量基团如本文所定义，以及它们的制备和使用。
• 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
  申请人：PFIZER INC.

  公开号：EP0156603A2

  公开（公告）日：1985-10-02

  2-Oxindole-1-carboxamides of the formula: and their pharmaceutically acceptable base-salts, where X and Y are certain optional substituents or can be taken together to form certain ring structures; and R1 is alkyl, cycloalkyl, cycloalkenyl, optionally substituted phenyl, optionally substituted phenylalkyl, optionally substituted phenoxyalkyl, (thiophenoxy) alkyl, naphthyl, bicyclo [2.2.1]heptan-2-yl, bicyclo [2.2.1]hept-5-en-2-yl or a group of the formula -(CH2)n-O-R° where n is 0, 1 or 2, Q is a divalent radical which is a specified heterocycle, and R° is H or alkyl. The compounds are useful as analgesic and anti-inflammatory agents. Also covered are certain intermediates useful in the preparation of the compounds (I), these intermediates having H in place of -CORI.

  式中的 2-吲哚-1-甲酰胺： 及其药学上可接受的碱基盐，其中 X 和 Y 是某些任选取代基，或可共同形成某些环结构；R1 是烷基、环烷基、环烯基、任选取代的苯基、任选取代的苯基烷基、任选取代的苯氧基烷基、（噻吩氧基）烷基、萘基、双环 [2.2.2.1]庚-2-基、双环[2.2.1]庚-5-烯-2-基或式-(CH2)n-O-R°的基团，其中 n 为 0、1 或 2，Q 为指定杂环的二价基，R° 为 H 或烷基。 这些化合物可用作镇痛剂和消炎剂。 此外，还包括某些用于制备化合物（I）的中间体，这些中间体中的 H 取代了-CORI。
• N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
  申请人：PFIZER INC.

  公开号：EP0164860A1

  公开（公告）日：1985-12-18

  Certain 2-oxindole-lcarboxamide compounds having an acyl substituent at the 3-position, and also further substituted on the carboxamide nitrogen by an alkyl, cycloalkyl, phenyl or substituted phenyl group, are inhibitors of the cyclooxygenase (CO) and lipoxygenase (LO) enzymes, and are useful as analgesic and antiinflammatory agents in mammalian subjects. These 2-oxindole-lcarboxamide compounds are of particular value for ameliorating pain in human patients recovering from surgery or trauma, and alleviating the symptoms of chronic diseases, such as rheumatoid arthritis and ostoarthritis, in human subjects. Certain 2-oxind ole-1-carboxamide compounds unsubstituted at C-3, but having a substituent on the carboxamide nitrogen, are useful as intermediates to the analgesic and antiinflammatory agents of the invention.

  某些 2-氧吲哚-甲酰胺化合物在 3 位上具有酰基取代基，在羧酰胺氮上还进一步被烷基、环烷基、苯基或取代苯基取代，是环氧化酶（CO）和脂氧合酶（LO）的抑制剂，可用作哺乳动物的镇痛剂和抗炎剂。这些 2-氧化吲哚-甲酰胺化合物对于改善手术或创伤后恢复期人类患者的疼痛，以及减轻人类慢性疾病（如类风湿性关节炎和骨关节炎）的症状具有特殊价值。 某些在 C-3 处未被取代但在羧酰胺氮上具有取代基的 2-氧代吲哚-1-甲酰胺化合物可作为本发明镇痛剂和抗炎剂的中间体。